成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海阿拉丁生化科技股份有限公司 Company Information

Company Name:	Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel:	400-6206333
Email:	market@aladdin-e.com
Nationality:	China
WebSite:	www.aladdin-e.com/
Product List:	48461

459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

Product List

Dehydroepiandrosterone sulfate

651-48-9

8-Azahypoxanthine

2683-90-1

Eculizumab (anti-Complement C5)

219685-50-4

Sirukumab (anti-IL-6)

1194585-53-9

Bimagrumab (anti-ACVR2B)

1356922-05-8

Ulocuplumab (anti-CXCR4)

1375830-34-4

Abelacimab(anti-Factor XI)

2098724-83-3

Tesnatilimab (anti-NKG2D)

2242758-08-1

Zansecimab (anti-ANGPT2)

2415205-37-5

Meropenem-d6

1133424-00-6

Ranibizumab (anti-VEGFA)

347396-82-1

2-(azetidin-1-yl)ethan-1-amine

795299-77-3

Enoblituzumab (anti-CD276)

1353485-38-7

Flanvotumab (anti-TYRP1)

1188277-05-5

Bermekimab (anti-IL-1a)

1401965-15-8

Inebilizumab (anti-CD19)

1299440-37-1

Prezalumab (anti-B7-H2)

1523164-68-2

Depatuxizumab mafodotin (anti-EGFR)

1585973-65-4

Tinurilimab (anti-CEACAM6)

2226224-30-0

Vandortuzumab (anti-STEAP1)

1557989-52-2

Galiximab (anti-CD80)

357613-77-5

Ethyl 2-oxo-4-phenylbutyrate

64920-29-2

Pascolizumab (anti-IL-4)

331243-22-2

Ocrelizumab (anti-CD20)

637334-45-3

Bis(hexamethylene)triamine

143-23-7

Ixekizumab (anti-CTLA-8)

1143503-69-8

Enokizumab (anti-IL-9)

909875-08-7

Concizumab (anti-TFPI)

1312299-39-0

Tarextumab (anti-NOTCH3)

1359940-55-8

Emibetuzumab (anti-MET)

1365287-97-3

Tesidolumab (anti-Complement C5)

1531594-08-7

Xentuzumab (anti-IGF1)

1417158-65-6

Lacnotuzumab (anti-M-CSF)

1831128-32-5

Ladiratuzumab (anti-SLC39A6)

1629760-28-6

Narsoplimab (anti-MASP2)

2108782-45-0

Belimumab (anti-TNFSF13B)

356547-88-1

IDO-IN-13

2291164-02-6

Benzyldiphenylphosphine

7650-91-1

Alizarin Yellow R sodium salt

1718-34-9

Eldelumab (anti-CXCL10)

946414-98-8

Tisotumab (anti-F3)

1418628-81-5

Vopratelimab (anti-ICOS)

2039148-04-2

Ragifilimab (anti-TNFRSF18)

2207590-51-8

Daclizumab (anti-IL2RA)

152923-56-3

Sonepcizumab (anti-Sphingosine-1-phosphate)

1031360-18-5

Rilotumumab (anti-HGF)

872514-65-3

Narnatumab (anti-RON)

1188275-92-4

Carotuximab (anti-CD105)

1268714-50-6

Brazikumab (anti-IL-23)

1610353-18-8

Ontamalimab (anti-MADCAM1)

2098790-40-8

Dostarlimab (anti-PD-1)

2022215-59-2

Avdoralimab (anti-C5AR1)

2226393-85-5

Datopotamab (anti-TROP2)

2267989-53-5

Denintuzumab (anti-CD19)

1630074-14-4

Mogamulizumab (anti-CCR4)

1159266-37-1

Rosmantuzumab (anti-RSPO3)

1684393-04-1

Ianalumab (anti-TNFRSF13C)

1929549-92-7

Quetmolimab (anti-CX3CL1)

2084037-83-0

Gemtuzumab (anti-CD33)

220578-59-6

Telazorlimab (anti-TNFRSF4)

2126777-87-3

Imazapic

104098-48-8

Guselkumab (anti-IL-23)

1350289-85-8

Labetuzumab govitecan (anti-CEACAM5)

1469876-18-3

Apamistamab (anti-PTPRC)

2097132-02-8

Sirtratumab (anti-SLITRK6)

1824663-82-2

Nadecnemab (anti-GFRA3)

2377679-19-9

Dysprosium(III) trifluoromethanesulfonate

139177-62-1

Efalizumab (anti-ITGAL)

214745-43-4

Elotuzumab (anti-SLAMF7)

915296-00-3

Oxelumab (anti-TNFSF4)

1186098-83-8

Seribantumab (anti-ERBB3)

1334296-12-6

Zagotenemab (anti-Tau)

2019133-28-7

Bexmarilimab (anti-STAB1)

2259301-27-2

Lemzoparlimab (anti-CD47)

2377483-71-9

Enfortumab (anti-NECTIN4)

1448664-46-7

KWAR23 (anti-SIRPg)

2243227-60-1

Lexatumumab (anti-TNFRSF10B)

845816-02-6

Bivatuzumab (anti-CD44v6)

214559-60-1

Urelumab (anti-TNFRSF9)

934823-49-1

Dinutuximab (anti-GD2)

1363687-32-4

Ravulizumab (anti-Complement C5)

1803171-55-2

Apelin 17 TFA

217082-57-0

Lumiliximab (anti-FceR2)

357613-86-6

Otilimab (anti-GM-CSF)

1638332-55-4

Fulranumab (anti-NGF)

902141-80-4

Vorsetuzumab (anti-CD70)

1165740-62-4

Vantictumab (anti-FZD)

1345009-45-1

Indusatumab (anti-GUCY2C)

1497400-26-6

Tamrintamab (anti-DPEP3)

2148325-59-9

Cinpanemab (anti-Alpha-synuclein)

2094516-02-4

Daxdilimab (anti-ILT7)

2245966-28-1

Idactamab (anti-SLC1A5)

2245205-37-0

Ponsegromab (anti-GDF15)

2368950-15-4

Gevokizumab (anti-IL-1b)

1129435-60-4

Itolizumab (anti-CD6)

1116433-11-4

Girentuximab (anti-CA9)

916138-87-9

Codrituzumab (anti-GPC3)

1365267-33-9

Vunakizumab (anti-IL-17a)

1792181-33-9

Imaprelimab (anti-CD146)

2014343-04-3

Serplulimab (anti-PDCD1)

2231029-82-4

459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485